The government is expected to introduce Evusheld, a COVID-19 antibody treatment that is administered to patients who do not form antibodies well even with vaccinations, to Korea this month.

Lee Ki-il, the first general coordinator of the Central Disaster and Safety Countermeasures Headquarters, presided over a meeting at the Sejong Government Complex on the 8th and said, "We will complete the EUA procedure of the Evusheld within June and guide local governments and the medical community." Lee Ki-il, the first general coordinator, explained, "It is a preventive antibody treatment for those who are difficult to form antibodies through vaccines because they are receiving immunosuppressants such as blood ca